Intuitive Surgical, Inc. vs Progressive Corp — how do they compare? Intuitive Surgical, Inc. trades at $403.57 (market cap $141.75B), while Progressive Corp trades at $208.49 (market cap $123.45B). The key difference: Intuitive Surgical, Inc. and Progressive Corp are close in size by market cap, and Progressive Corp pays a 6.55% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | PGR | |
|---|---|---|
Market Cap | $141.75B | $123.45B |
Sector | Health | Financials |
52-Week High | $592.85 | $252.68 |
52-Week Low | $332.02 | $190.40 |
Enterprise Value | $136.53B | $131.66B |
Dividend Yield | — | 6.55% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $393.38, up 3.85% on the day, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The stock exhibits premium valuation metrics, including a P/E of 46.01 and P/S of 13.08, supported by robust revenue growth, which reached $10.06B in 2025, and high net income margins of 28.45%. Recent news highlights analyst upgrades and optimism around the da Vinci 5 system's adoption.
The outlook remains positive given durable demand and innovation, but risks include heightened competition and valuation sensitivity. Wall Street consensus is bullish with a $518.10 price target, implying significant upside, though investors should weigh premium multiples against growth sustainability and competitive pressures in the medtech space.
Progressive (PGR) trades at $213.95, down 0.64% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamental performance with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Recent Q2 2026 earnings beat expectations at $4.85 per share, though the combined ratio widened to 87.1%, indicating potential growth trade-offs. Analyst consensus price target stands at $231.20 with 37% buy ratings.
PGR presents a compelling investment case with reasonable valuation (P/E 10.65) and strong profitability (ROE 34.94%), though investors face risks from competitive pressures and potential margin compression as the company expands its bundled insurance offerings. The stock offers 8% upside to consensus target with balanced risk-reward profile.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →